MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Начало・Списък с акции・Microbot Medical Inc

Microbot Medical Inc

Затворен

2.49 0.4

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.44

Максимум

2.49

Ключови измерители
By Trading Economics
Приходи	791K -2.6M
Служители	20
EBITDA	-127K -3.4M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+262.9% upside

Дивиденти
By Dow Jones
Следващи печалби	12.08.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	2.5M 95M
Предишно отваряне	2.09
Предишно затваряне	2.49

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

2.52 / 2.57 Подкрепа & съпротива

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.07.2025 г., 15:46 ч. UTC

Значими двигатели на пазара

BitMine Shares Fall After Closing of $250 Million Private Placement

9.07.2025 г., 23:44 ч. UTC

Пазарно говорене

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9.07.2025 г., 23:42 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

9.07.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9.07.2025 г., 22:59 ч. UTC

Пазарно говорене

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9.07.2025 г., 22:59 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

9.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

9.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.07.2025 г., 20:26 ч. UTC

Печалби

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9.07.2025 г., 19:18 ч. UTC

Пазарно говорене

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9.07.2025 г., 19:03 ч. UTC

Пазарно говорене

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9.07.2025 г., 18:31 ч. UTC

Пазарно говорене

Some Fed Officials Supported Considering July Cut -- Market Talk

9.07.2025 г., 17:07 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk -2-

9.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

9.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.07.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

9.07.2025 г., 16:14 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

9.07.2025 г., 16:14 ч. UTC

Пазарно говорене

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9.07.2025 г., 16:14 ч. UTC

Придобивния, сливания и поглъщания

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9.07.2025 г., 16:12 ч. UTC

Пазарно говорене

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9.07.2025 г., 16:08 ч. UTC

Пазарно говорене

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9.07.2025 г., 15:31 ч. UTC

Значими двигатели на пазара

BitMine Shares Fall After Closing of $250M Private Placement

9.07.2025 г., 15:31 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9.07.2025 г., 15:27 ч. UTC

Пазарно говорене

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9.07.2025 г., 14:36 ч. UTC

Придобивния, сливания и поглъщания

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9.07.2025 г., 14:31 ч. UTC

Придобивния, сливания и поглъщания

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9.07.2025 г., 14:26 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

9.07.2025 г., 14:26 ч. UTC

Пазарно говорене

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

262.9% нагоре

12-месечна прогноза

Среден 9 USD 262.9%

Висок 9 USD

Нисък 9 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Microbot Medical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.